| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,406 |
6,055 |
$4.38M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,028 |
1,879 |
$571K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
509 |
499 |
$206K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,841 |
1,752 |
$159K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,810 |
1,737 |
$155K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,881 |
1,701 |
$108K |
| 80053 |
Comprehensive metabolic panel |
12,858 |
11,576 |
$95K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
13,237 |
11,728 |
$62K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
358 |
341 |
$61K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,841 |
2,692 |
$53K |
| 76801 |
|
506 |
441 |
$50K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
335 |
293 |
$28K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
125 |
125 |
$25K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,214 |
1,147 |
$23K |
| 70450 |
Computed tomography, head or brain; without contrast material |
488 |
474 |
$23K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
747 |
712 |
$18K |
| 71045 |
Radiologic examination, chest; single view |
1,394 |
1,308 |
$17K |
| G0378 |
Hospital observation service, per hour |
329 |
313 |
$16K |
| 84703 |
|
2,867 |
2,667 |
$14K |
| 83880 |
|
1,331 |
1,224 |
$13K |
| 81001 |
|
4,891 |
4,566 |
$12K |
| 84484 |
|
2,842 |
1,560 |
$10K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,127 |
992 |
$9K |
| 87088 |
|
1,535 |
1,438 |
$7K |
| 84702 |
|
717 |
622 |
$7K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
98 |
87 |
$4K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
44 |
42 |
$4K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
180 |
157 |
$4K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
413 |
399 |
$3K |
| 86850 |
|
169 |
149 |
$3K |
| 83690 |
|
945 |
870 |
$3K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
40 |
38 |
$3K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
24 |
24 |
$2K |
| 86901 |
|
905 |
827 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
845 |
776 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
548 |
434 |
$2K |
| 85730 |
|
718 |
679 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,291 |
1,112 |
$2K |
| 85610 |
|
971 |
884 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
82 |
81 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
327 |
294 |
$1K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
457 |
361 |
$858.98 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
44 |
44 |
$838.35 |
| CP007 |
|
14 |
14 |
$686.00 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
25 |
25 |
$638.06 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
54 |
54 |
$626.39 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
635 |
543 |
$532.62 |
| 86900 |
|
229 |
204 |
$514.67 |
| 87077 |
|
131 |
114 |
$384.52 |
| 87400 |
|
30 |
29 |
$261.76 |
| 83735 |
|
99 |
77 |
$248.65 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
96 |
84 |
$242.40 |
| 81025 |
|
41 |
40 |
$200.03 |
| 87070 |
|
33 |
31 |
$180.12 |
| 83605 |
|
96 |
52 |
$163.88 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
41 |
38 |
$44.21 |
| 87040 |
|
24 |
12 |
$34.68 |
| 82550 |
|
19 |
15 |
$27.35 |
| 87186 |
|
12 |
12 |
$14.54 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
16 |
13 |
$2.97 |
| 36415 |
Collection of venous blood by venipuncture |
764 |
672 |
$1.80 |
| J2704 |
Injection, propofol, 10 mg |
108 |
89 |
$0.00 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
14 |
14 |
$0.00 |